Sublingual or subcutaneous immunotherapy for allergic rhinitis?
about
Allergen-specific immunotherapy: is it vaccination against toxins after all?Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms.Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical TrialA practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice.Asthma phenotypes in children and stratified pharmacological treatment regimens.Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.Investigational new drugs for allergic rhinitis.Adjuvants for allergy immunotherapeutics.Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells.Ultra-short-course booster is effective in recurrent grass pollen-induced allergic rhinoconjunctivitis.Effect of adjuvanted and standard sublingual immunotherapy on respiratory function in pure rhinitis due to house dust mite over a 5-year period.Allergic rhinitis: the eligible candidate to mite immunotherapy in the real world.Quality of life improvement after a three-year course of sublingual immunotherapy in patients with house dust mite and grass pollen induced allergic rhinitis: results from real-lifeA Retrospective Study of Clinical Response Predictors in Subcutaneous Allergen Immunotherapy With House Dust Mites for Allergic Rhinitis.Immunotherapy for pet allergies.The relevance of house dust mites allergy in clinical practice: the epidemiological impact on allergen immunotherapy.Next generation immunotherapy for tree pollen allergies.Subcutaneous versus sublingual immunotherapy.All change…transcanal endoscopic ear surgery and house dust mite immunotherapy for allergic rhinitis.A roadmap towards personalized immunology.Tregitope-linked Refined Allergen Vaccines for Immunotherapy in Cockroach AllergyDuration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis
P2860
Q30248317-E42964C5-BCBD-4BF7-8FC8-FF02E2B52E34Q37623049-D617B80B-CC5C-451E-B18D-CCE87FDB92BEQ38380837-1FF442D5-4C20-4529-8695-2A01E5134B5EQ38888019-44D1E446-F043-411C-AF3F-03248A272717Q39034456-5CD1F23B-0588-41F5-A2ED-6F9A438832ADQ39037216-BBB6C51A-1798-4213-B892-6573B757FAF9Q39111947-3D3EBE9A-2D5C-4F76-B036-6668C5D8BAEBQ39151158-C9D1D88B-C31B-4AA7-87B9-0775DE54BF83Q39402881-AE489337-21ED-4D63-97D5-39114747B1FDQ40135722-BE9DF79F-EBA2-4279-8991-4D7585C7B889Q41854493-B5351BD0-AD6A-44F0-87C9-50E4D62ACC58Q41861659-4FCC8CBF-9571-4D14-9B0E-6C0E9CC8D041Q42368155-476D185C-5497-4E6F-888F-6924F422C543Q47101522-62F15113-555E-47E8-BE02-9611C5563257Q47697735-DACDB79D-B4A6-43F7-85FD-380AAA4EE3ADQ47713962-94B2322D-2044-4B5E-9772-CAF90E4BDC82Q47884083-D2CD2345-9BAD-43B1-8C2D-89A966D0BBA1Q48053554-F96DD11F-2720-4B34-A276-49ABAC6A7B72Q49928702-EFA77B95-6378-4196-843C-5B1F6B76ACADQ50104991-66DED346-38AB-4260-A75B-F9C0CC3B5564Q57811623-477E6072-6545-4935-9DAC-1146E8AABE4BQ58780229-42F4593F-CD27-48EC-8093-6A3A9DEEC148
P2860
Sublingual or subcutaneous immunotherapy for allergic rhinitis?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Sublingual or subcutaneous immunotherapy for allergic rhinitis?
@en
type
label
Sublingual or subcutaneous immunotherapy for allergic rhinitis?
@en
prefLabel
Sublingual or subcutaneous immunotherapy for allergic rhinitis?
@en
P1476
Sublingual or subcutaneous immunotherapy for allergic rhinitis?
@en
P2093
Stephen R Durham
P304
339-349.e10
P356
10.1016/J.JACI.2015.12.1298
P407
P577
2016-02-01T00:00:00Z